Background
Korean pharmaceutical companies have excelled in biosimilar, cell therapy, and CDMO, positioning them to pursue innovative technologies and drug developments. Partnering with Sweden's thriving pharmaceutical and biotech sector, Business Sweden aimed to enhance cooperation between Sweden and South Korea. At Bio Korea 2025, Swedish delegates can showcase their innovative life science pipelines and technologies, fostering business collaborations between the two nations.
Why Join?
- Opportunity for Swedish companies to showcase innovative technology and explore business collaborations in conjunction with Bio Korea 2025.
- To foster collaboration and partnerships between Sweden and Korean biopharma companies for future opportunities.
- To expand the market presence of Swedish companies by connecting with potential partners in Korea.
- To highlight cutting-edge technologies and innovative solutions offered by Swedish companies in the life science sector.
- To support Swedish companies by providing them with a platform to network, showcase their technologies